The international normalized ratio calibrated for cirrhosis (INR liver) normalizes prothrombin time results for model for end-stage liver disease calculation

Hepatology

Volumn 46, Issue 2, 2007, Pages 520-527

  Tripodi, Armando ^a,b   Chantarangkul, Veena ^a   Primignani, Massimo ^a   Fabris, Federica ^a   Dell'Era, Alessandra ^a   Sei, Cinzia ^a   Mannucci, Pier Mannuccio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Mangiagalli and Regina Elena Foundation ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; BILIRUBIN; CREATININE; THROMBOPLASTIN;

ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PROTHROMBIN TIME;

ADULT; CALIBRATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; MODELS, THEORETICAL; PROTHROMBIN TIME; SEVERITY OF ILLNESS INDEX;

EID: 34250892300     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21732     Document Type: Article

References (19)

1. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. HEPATOLOGY 2000;31:864-871.
2. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor liver. Gastroenterology 2003;124:91-96.
3. Trotter JF, Brimhall B, Arjal R. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004;10:995-1000.
4. Kenison J, Arjal R, Smith A, Brimhall B, Phillips C, Olson J, et al. Interlaboratory variation in INR leads to clinically relevant changes in MELD score: survey of US clinical laboratories [Abstract]. Am J Transpl 2006;6(Suppl 2):333.
5. Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio. HEPATOLOGY 1996;24:1392-1394.
6. Kovacs MJ, Wong A, MacKinnon K, Weir K, Keeney M, Boyle E, et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Hemost 1994;71:727-730.
7. Denson KW, Reed SV, Haddon ME, Woodhams B, Brucato C, Ruiz J. Comparative studies of rabbit and human recombinant tissue factor reagents. Thromb Res 1999;94:255-261.
8. Tripodi A, Chantarangkul V, Negri B, Clerici M, Mannucci PM. International Collaborative study for the calibration of a proposed reference preparation for thromboplastin, human recombinant, Plain. Thromb Haemost 1998;79:439-443.
9. van den Besselaar AMHP, Poller L, Tripodi A. Guidelines for thromboplastins and plasmas used to control oral anticoagulant therapy (1999). WHO Technical Report Ser 1999;889:64-93.
10. Quick AJ. The prothrombin in hemophilia and in obstructive jaundice. J Biol Chem 1935;109:73-74.
11. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl):204S-233S. Erratum in: Chest 2005;127:415-416. Dosage error in text.
12. Kirkwood TB. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983;49:238-244.
13. WHO Expert Committee on Biological Standardisation. 33rd Report. WHO Technical Report Series 1983;687:81-105.
14. van den Besselaar AMHP, Barrowcliffe TW, Houbouyan-Réveillard LL, Jespersen J, Johnston M, Poller L, et al., on behalf of the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the ISTH. Guidelines on preparation, certification and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost 2004;2:1946-1953.
15. Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for control of oral anticoagulant treatment by the international normalized ratio? Thromb Haemost 1993;70:921.
16. Tripodi A, Chantarangkul V, Mannucci PM. Near patient testing devices to monitor oral anticoagulant therapy. Br J Haematol 2001;113:847-852.
17. Chantarangkul V, Tripodi A, Cesana BM, Mannucci PM. Calibration of local systems for International Normalized Ratio (INR) with lyophilized calibrant plasmas improves the interlaboratory variability of the INR in the Italian External Quality Assessment Scheme. Thromb Haemost 1999;82:1621-1626.
18. Tripodi A. Hemostasis in chronic liver disease. J Thromb Haemost 2006;4:2064-2065.
19. Deitcher SR. Interpretation of the international normalised ratio in patients with liver disease. Lancet 2002;359:47-48.